Mucormycosis in Australia: contemporary epidemiology and outcomes

Clinical Microbiology and Infection

Volumn 22, Issue 9, 2016, Pages 775-781

  Kennedy, Karina ^r   Daveson, Kathryn ^r   Slavin, Monica ^r   van Hal, Sebastian ^r   Sorrell, Tania ^r   Lee, A ^c   Marriott, Deborah ^r   Chapman, B ^f,g   Halliday, Catriona ^r   Hajkowicz, K ^h   Athan, E ⁱ   Bak, Narin ^r   Cheong, E ^k   Heath, Christopher ^r   Morrissey, C Orla ^r   Kidd, Sarah ^r   Beresford, R ^o   Blyth, Christopher ^r   Korman, T M ^m   Robinson, J O ^l,q   Meyer, Wieland ^r   Chen, S C A ^f,g   Clark, Julia ^r   McCormack, Joseph ^r   Looke, David ^r   Playford, E Geoffrey ^r   Chen, Sharon ^r   McMullan, Brendan ^r   Ananda Rajah, Michelle ^r   Arthur, Ian ^r   Morris, Arthur ^r   Chambers, Steve ^r   more..

^a CANBERRA HOSPITAL   (Australia)

^b PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d University of Sydney   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g WESTMEAD HOSPITAL   (Australia)

^h ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

ⁱ BARWON HEALTH   (Australia)

^j ROYAL ADELAIDE HOSPITAL   (Australia)

^k Department of Microbiology and Infectious Diseases   (Australia)

^l UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^m MONASH UNIVERSITY   (Australia)

ⁿ SA Pathology   (Australia)

^o LIVERPOOL HOSPITAL   (Australia)

^p UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^q CURTIN UNIVERSITY   (Australia)

^r Murdoch University ^*

more..

Author keywords

Apophysomyces; epidemiology; mortality; Mucorales; mucormycete; mucormycosis; Rhizopus; Saksenaea; zygomycosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CALCINEURIN INHIBITOR; CASPOFUNGIN; CORTICOSTEROID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLIXIMAB; POSACONAZOLE; RITUXIMAB; TERBINAFINE; VORICONAZOLE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ANTIFUNGAL THERAPY; APOPHYSOMYCES; ARTICLE; AUSTRALIA; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE HEPATITIS; BONE INFECTION; BRAIN INFECTION; BURN; CAUSE OF DEATH; CHEMOTHERAPY; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE PREDISPOSITION; EYE INFECTION; FEMALE; FUNGUS CULTURE; FUSARIOSIS; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INFECTIOUS ARTHRITIS; INJURY; INTENSIVE CARE UNIT; KETOACIDOSIS; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MICROBIAL IDENTIFICATION; MORTALITY; MUCOR CIRCINELLOIDES; MUCORMYCOSIS; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SKIN INFECTION; SOFT TISSUE INFECTION; SPECIES; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TRAFFIC ACCIDENT; TREATMENT DURATION; VASCULITIS; ADOLESCENT; AGED; CLINICAL TRIAL; COMORBIDITY; DISEASE MANAGEMENT; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUSTRALIA; COMORBIDITY; DISEASE MANAGEMENT; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCORMYCOSIS; PATIENT OUTCOME ASSESSMENT; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84964608282     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.01.005     Document Type: Article

References (27)

1. [1] Roden, M.M., Zaoutis, T.E., Buchanan, W.L., Knudsen, T.A., Sarkisova, T.A., Schaufele, R.L., et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41 (2005), 634–653.
2. [2] Lanternier, F., Dannaoui, E., Morizot, G., Elie, C., Garcia-Hermoso, D., Huerre, M., et al. A global analysis of mucormycosis in France: the RetroZygo study (2005–2007). Clin Infect Dis 54:S1 (2012), S35–S43.
3. [3] Skiada, A., Pagano, L., Groll, A., Zimmerli, S., Dupont, B., Lagrou, K., et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 17 (2011), 1859–1867.
4. [4] Bitar, D., Van Cauteren, D., Lanternier, F., Che, D., Dromer, F., Desenclos, J.C., et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis 15 (2009), 1395–1401.
5. [5] Kontoyiannis, D.P., Azie, N., Franks, B., Horn, D.L., Prospective antifungal therapy (PATH) alliance: focus on mucormycosis. Mycoses 57 (2014), 240–246.
6. [6] Ruping, M.J.G.T., Heinz, W.J., Kindo, A.J., Rickerts, V., Lass-Florl, C., Beisel, C., et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother 65 (2010), 296–302.
7. [7] Chakrabarti, A., Singh, R., Mucormycosis in India: unique features. Mycoses 57:S3 (2014), 85–90.
8. [8] Lelievre, L., Garcia-Hermoso, D., Abdoul, H., Hivelin, M., Chouaki, T., Toubas, D., et al. Posttraumatic mucormycosis. A nationwide study in France and review of the literature. Med (Balt) 93 (2014), 395–404.
9. [9] Slavin, M.A., Chakrabarti, A., Opportunistic fungal infections in the Asia-Pacific region. Med Mycol 50 (2012), 18–25.
10. [10] Austin, C.L., Finley, P.J., Mikkelson, D.R., Tibbs, B., Mucormycosis: a rare fungal infection in tornado victims. J Burn Care Res 35 (2014), e164–71.
11. [11] Cheng, V.C.C., Chan, J.F.W., Ngan, A.H.Y., To, K.K.W., Leung, S.Y., Tsoi, H.W., et al. Outbreak of intestinal infection due to Rhizopus microsporus. J Clin Microbiol 47 (2009), 2834–2843.
12. [12] Chakrabarti, A., Das, A., Mandal, J., Shivaprakash, M.R., George, V.K., Tarai, B., et al. The rising trend of invasive mucormycosis in patients with uncontrolled diabetes mellitus. Med Mycol 44 (2006), 335–342.
13. [13] Slavin, M., van Hal, S., Sorrell, T.C., Lee, A., Marriott, D.J., Daveson, K., et al. Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clin Microbiol Infect, 21, 2015 490.e1–10.
14. th revision. Australian modification (ICD-10-AM), 1998, The Centre, University of Sydney, Sydney.
15. [15] De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., et al. European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46 (2008), 1813–1821.
16. [16] Ciardo, D.E., Lucke, K., Imhof, A., Bloemberg, G.V., Bottger, E.C., Systematic internal transcribed spacer sequence analysis for identification of clinical mould isolates in diagnostic mycology: a 5-year study. J Clin Microbiol 48 (2010), 2809–2813.
17. [17] Kurtzman, C.P., Robnett, C.J., Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 35 (1997), 1216–1223.
18. [18] Lau, A., Chen, S., Sorrell, T., Carter, D., Malik, R., Martin, P., et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol 45 (2007), 380–385.
19. [19] Park, B.J., Pappas, P.G., Wannemuehler, K.A., Alexander, B.D., Anaissie, E.J., Andes, D.R., et al. Invasive non-aspergillus mold infections in transplant recipients, United States, 2001–2006. Emerg Infect Dis 17 (2011), 1855–1864.
20. [20] Ambrosioni, J., Bouchuiguir-Wafa, K., Garbino, J., Emerging invasive zygomycosis in a tertiary care centre: epidemiology and associated risk factors. Int J Infect Dis, 2010 14S:e100–3.
21. [21] Gomes, M.Z.R., Lewis, R.E., Kontoyiannis, D.P., Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev 24 (2011), 411–445.
22. [22] Royer, M., Puechal, X., Mucormycosis in systemic autoimmune disease. Joint Bone Spine 81 (2014), 303–307.
23. [23] Ingram, P.R., Suthananthan, A.E., Rajan, R., Pryce, T.M., Sieunarine, K., Gardam, D.J., et al. Cutaneous mucormycosis and motor vehicle accidents: findings from an Australian case series. Med Mycol 52 (2014), 819–825.
24. [24] Cornely, O.A., Arikan-Akdagli, S., Dannaoui, E., Groll, A.H., Lagrou, K., Chakrabarti, A., et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect S3 (2014), 5–26.
25. [25] Lackner, M., Caramalho, R., Lass-Florl, C., Laboratory diagnosis of mucormycosis: current status and future perspectives. Future Microbiol 9 (2014), 683–695.
26. [26] Abotlins, C.A., Pratt, W.A.B., Solano, T.R., Fungemia secondary to gastrointestinal Mucor indicus infection. Clin Infect Dis 42 (2006), 154–155.
27. [27] Chan-Tuck, K.M., Nemoy, L.L., Perencevich, E.N., Central venous catheter-associated fungemia secondary to mucormycosis. Scand J Infect Dis 37 (2005), 925–927.